Substance / Medication

Levamisole

Overview

Active Ingredient
levamisole
RxNorm CUI
6371

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Levamisole-induced vasculopathy: A systematic review.
Dartevel Anaïs, Chaigne Benjamin, Moachon Laurence et al. · Semin Arthritis Rheum · 2019
PMID: 30166200Meta-Analysis
Meta-analysis: levamisole improves the immune response to hepatitis B vaccine in dialysis patients.
Fabrizi F, Dixit V, Messa P et al. · Aliment Pharmacol Ther · 2010
PMID: 20662784Meta-Analysis
Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial.
Chesnais Cédric B, Hemilembolo Marlhand C, Sahm Bachiratou A et al. · Nat Commun · 2025
PMID: 40615414RCTFull text (PMC)
Effectiveness of levamisole in the treatment of patients with severe COVID-19: a randomized controlled clinical trial.
Pourahmad Morteza, Soltani Rasool, Noroozi Mohammad H et al. · J Infect Dev Ctries · 2024
PMID: 39863943RCT
Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study.
Banerjee Sushmita, Sengupta Jayati, Sinha Rajiv et al. · Pediatr Nephrol · 2024
PMID: 38822220RCT
Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial.
Campillo Jérémy T, Bikita Paul, Hemilembolo Marlhand et al. · Clin Infect Dis · 2022
PMID: 34651190RCTFull text (PMC)
Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial.
Roostaei Firozabad Amirreza, Meybodi Zohreh Akhoundi, Mousavinasab Seyed Ruhollah et al. · BMC Infect Dis · 2021
PMID: 33761870RCTFull text (PMC)
The Effect of Oral Levamisole Co-administration on the Level of Immune Response to Hepatitis B Vaccine in Healthy Individuals: A Randomized Clinical Trial.
Hosseini Mousalreza, Shalchiantabrizi Payman, Dadgarmoghaddam Maliheh et al. · Iran J Allergy Asthma Immunol · 2017
PMID: 28732435RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Levamisole (substance)
SNOMED CT
387296006
UMLS CUI
C0023556
RxNorm CUI
6371

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.